1. Home
  2. GCV vs SEER Comparison

GCV vs SEER Comparison

Compare GCV & SEER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gabelli Convertible and Income Securities Fund Inc. (The)

GCV

Gabelli Convertible and Income Securities Fund Inc. (The)

HOLD

Current Price

$4.66

Market Cap

92.7M

Sector

Finance

ML Signal

HOLD

Logo Seer Inc.

SEER

Seer Inc.

HOLD

Current Price

$2.17

Market Cap

97.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GCV
SEER
Founded
N/A
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
92.7M
97.3M
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
GCV
SEER
Price
$4.66
$2.17
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
50.2K
1.2M
Earning Date
01-01-0001
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
9.40
EPS
N/A
N/A
Revenue
N/A
$16,578,000.00
Revenue This Year
N/A
$2.14
Revenue Next Year
N/A
$25.90
P/E Ratio
N/A
N/A
Revenue Growth
N/A
16.99
52 Week Low
$3.88
$1.55
52 Week High
$4.77
$2.41

Technical Indicators

Market Signals
Indicator
GCV
SEER
Relative Strength Index (RSI) 49.33 72.61
Support Level $4.35 $2.15
Resistance Level $4.77 $2.40
Average True Range (ATR) 0.08 0.07
MACD -0.01 0.06
Stochastic Oscillator 47.06 81.02

Price Performance

Historical Comparison
GCV
SEER

About GCV Gabelli Convertible and Income Securities Fund Inc. (The)

GABELLI CONVERTIBLE & INCOME SECURITIES FUND INC is a diversified closed-end management investment company. Its investment objective is to seek a high level of total return through a combination of current income and capital appreciation by investing in convertible securities. The company invests in various portfolios such as Health Care, Financial Services, Real Estate Investment Trust, Energy and Utilities, Telecommunications, Food and Beverage, Aerospace and Automotive, and others. All the operation of the group is operated through the regions of the United States.

About SEER Seer Inc.

Seer Inc is a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa.

Share on Social Networks: